首页|First Affiliated Hospital of University of Science and Technology China (USTC) R eports Findings in Artificial Intelligence (Prediction of epidermal growth facto r receptor mutation subtypes in non-small cell lung cancer from hematoxylin and ...)

First Affiliated Hospital of University of Science and Technology China (USTC) R eports Findings in Artificial Intelligence (Prediction of epidermal growth facto r receptor mutation subtypes in non-small cell lung cancer from hematoxylin and ...)

扫码查看
原文链接
  • NETL
  • NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating in Anhui, People’s Republic of China, by NewsRx journalists, research stated, “Accurate as sessment of epidermal growth factor receptor (EGFR) mutation status and subtype are critical for the treatment of non-small cell lung cancer (NSCLC) patients. C onventional molecular testing methods for detecting EGFR mutations have limitati ons.”

AnhuiPeople's Republic of ChinaAsiaArtificial IntelligenceCancerEmerging TechnologiesEpidermal Growth Factor ReceptorEpidermal Growth FactorsGastrointestinal Hormone ReceptorsGastroi ntestinal HormonesGeneticsGrowth Factor ReceptorsHealth and MedicineHosp italsIntercellular Signaling Peptides and ProteinsLung CancerLung Diseases and ConditionsLung NeoplasmsMachine LearningMembrane ProteinsNon-Small Cell Lung CancerOncologyPeptide ReceptorsPhosphotransferasesProtein Kina sesReceptor Protein-Tyrosine Kinases

2024

Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN：
年,卷(期)：2024.(Jul.2)